Using RNAi and CRISPR Screening to Elucidate Biological Pathways
In this GEN webinar, our expert speakers, Mikella Robinson, PhD, and Constantinos Demetriades, PhD, will share results from two studies that demonstrate the power of RNAi and CRISPR screening to elucidate the activity of important biological networks and pathways.
Accelerating mRNA-LNP Formulation Screening for Genomic Drug Discovery and Development
In this GEN webinar, sponsored by Unchained Labs, our expert speakers will discuss strategies and tools for rapidly formulating and characterizing LNPs for drug discovery and development.
Neurodegenerative Disease Biomarker Detection Using an Ultra-Sensitive Profiling Method
In TODAY’s GEN webinar, sponsored by Alamar Biosciences, Henrik Zetterberg, MD, PhD, an expert in Alzheimer’s disease from the University of Gothenburg, will discuss his efforts to discover and validate blood-based biomarkers for various CNS disorders.
Microbial Expression Systems Get a Much Needed Upgrade
In TOMORRROW’s GEN webinar, Dr. Nordwald from KBI Biopharma will discuss how the groundbreaking PUREplatform improves microbial therapeutic protein expression. You’ll learn how PUREplatform can transform microbial drug substance production at a fraction of the scales previously needed.
Effective Engineering of Bispecific/Multispecific Antibodies for Biotherapeutics Development
In Monday’s GEN webinar, Dr. Jianqing Xu, Head of the Protein Design and Engineering Excellence Center at WuXi Biologics, will discuss tools and strategies for effectively addressing the technical challenges of engineering bispecific and multispecific antibodies.
Scaled Up Production of mRNA-LNPs: Strategies & Parameters
In this webinar, our expert Midhun Ben Thomas, PhD, from CPI will discuss the strategies for scaling up mRNA-LNP production in which the encapsulation approach, method of buffer exchange, and filtration all play a significant role.
Solutions for In-Process Monitoring of Critical Quality Attributes in Bioprocessing
Improving process understanding allows process engineers to develop manufacturing processes that reduce the potential for batch failure or manufacturing delay. this GEN talk, sponsored by Waters, describes the automation of routine product quality and cell culture media analysis to eliminate human errors with automated sample preparation and data transfer.
CRISPR Cures 2033: Expanding the Public Health Impact of Gene Editing
In this live webinar, sponsored by Aldevron, one of the pioneers of human genome editing—Dr. Fyodor Urnov—will lay out the urgent challenge facing the clinical genome editing community in terms of expanding the public health impact of CRISPR-Cas.
AVITI™ in Action: Any Scale, Any Application
In TODAYs webinar, you’ll receive an in-depth introduction to Element Biosciences’ AVITI through an engaging panel discussion and audience Q&A session with a trio of NGS experts who have hands-on experience with AVITI.
Biopharma Tech Strategies in an Era Defined by Data and AI
In TODAY’s GEN webinar, Malay Gandhi, Head of Strategy at Benchling, will discuss hurdles that biopharma needs to overcome to deploy a solid tech strategy as well as the key technologies that companies are investing in.
An Automated Imaging Strategy for Characterizing Particles in Biotherapeutic Stability Studies
In this webinar, sponsored by Halo Labs, you’ll learn how Aura+ leverages innovative modern imaging and fluorescence microscopy techniques developed specifically for the life sciences to characterize protein, gene, and cell therapy products in stability studies.
Accelerating mRNA-LNP Medicine Development from Concept to Clinic
In this GEN webinar, three experts will discuss how Precision Nanosystems’ modular microfluidic platform technologies and analytics can help scientists successfully design, develop, test, and scale-up promising mRNA-LNP vaccines and therapeutics from concept to clinic.
Strategies for Multi-Omic Analysis of Ovarian Tumor Tissue Using Imaging Mass Cytometry™
In thi’s GEN webinar, sponsored by Standard BioTools, Dr. Sammy Ferri-Borgogno, from MD Anderson Cancer Center, will discuss how a multi-omic approach to tissue imaging can reliably characterize the tumor microenvironment in ovarian cancer.
Beyond AAV: Novel Strategies for Genetic Payload and Delivery Systems
In TODAY’s cell and gene therapy webinar, sponsored by Revvity, our distinguished speakers, Dr. Dominik Fischer and Dr. Michelle Fraser, will discuss recent advances and novel strategies for genetic modulation and payload delivery systems.
Host Cell Protein (HCP) Profiling and Quantitation in Gene Therapy Products with the Orbitrap Astral Mass Spectrometer
In this webinar, sponsored by Thermo Fisher Scientific, our special guest Jonathan Bones from NIBRT, will demonstrate approaches to over come key challenges with AAV HCP analysis, such as the highly complex proteome background and large dynamic range which necessitate the need for high sensitivity enabling the detection and quantification of low abundant HCPs, essential for safe and efficacious production of these advanced biotherapeutics.
doggybone DNA: A Rapid Enzymatic GMP Starting Material for mRNA Production
In this GEN webinar, presenters Benyamin Panah, PhD, RNA subject matter expert, Touchlight, and Scott Alderucci, director of process development, Curia, will address the evolving challenges of pDNA in mRNA manufacture, and discuss an alternative to pDNA—an enzymatic, antibiotic-free DNA vector called doggybone DNA (dbDNA™).